Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer

M Carbone, JW Harbour, J Brugarolas, A Bononi… - Cancer discovery, 2020 - AACR
Among more than 200 BAP1-mutant families affected by the “BAP1 cancer syndrome,”
nearly all individuals inheriting a BAP1 mutant allele developed one or more malignancies …

Malignant mesothelioma and its non-asbestos causes

RL Attanoos, A Churg… - … of pathology & …, 2018 - meridian.allenpress.com
Context.—Although many mesotheliomas are related to asbestos exposure, not all are, and
there is increasing information on other causes of mesothelioma. Objective.—To provide a …

[HTML][HTML] Journey to the centre of the lung. The perspective of a mineralogist on the carcinogenic effects of mineral fibres in the lungs

AF Gualtieri - Journal of Hazardous Materials, 2023 - Elsevier
This work reviews the bio-chemical mechanisms leading to adverse effects produced when
mineral fibres are inhaled and transported in the lungs from the perspective of a …

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases

K Rai, R Pilarski, CM Cebulla… - Clinical …, 2016 - Wiley Online Library
The BRCA1‐associated protein‐1 (BAP1) tumor predisposition syndrome (BAP1‐TPDS) is a
recently identified hereditary cancer syndrome. Germline mutations in this tumor suppressor …

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations

BS Sheffield, HC Hwang, AF Lee… - The American journal …, 2015 - journals.lww.com
A variety of immunohistochemical (IHC) stains have been proposed to mark either benign or
malignant mesothelial proliferations. Loss of the p16 tumor suppressor (CDKN2A), through …

[HTML][HTML] BAP1 tumor predisposition syndrome

R Pilarski, MI Carlo, C Cebulla, M Abdel-Rahman - 2022 - europepmc.org
BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for
a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical …

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

F Lalloo, A Kulkarni, C Chau, M Nielsen… - European Journal of …, 2023 - nature.com
Abstract BRCA1-associated protein-1 (BAP1) is a recognised tumour suppressor gene.
Germline BAP1 pathogenic/likely pathogenic variants are associated with predisposition to …

Loss of expression of BAP1 predicts longer survival in mesothelioma

M Farzin, CW Toon, A Clarkson, L Sioson, N Watson… - Pathology, 2015 - Elsevier
Summary BRCA1-associated protein 1 (BAP1) is a tumour suppressor gene frequently
inactivated in mesothelioma, rarely also in association with germline mutation. BAP1 …

[HTML][HTML] BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large …

L Righi, E Duregon, S Vatrano, S Izzo, J Giorcelli… - Journal of Thoracic …, 2016 - Elsevier
Introduction Malignant pleural mesothelioma (MPM) is a highly aggressive disease with
limited therapeutic options. Histological subtype remains among the most reliable prognostic …

Genotypic and phenotypic features of BAP1 cancer syndrome: a report of 8 new families and review of cases in the literature

AM Haugh, CN Njauw, JA Bubley, AE Verzì… - JAMA …, 2017 - jamanetwork.com
Importance Patients with germline mutations inBAP1may develop several flesh-colored
melanocyticBAP1–mutated atypical intradermal tumors (MBAITs). These tumors generally …